Funding Agreements in the Biotechnology Industry

54 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Funding contract, dated July 2, 2012, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding Agreement by and between the Registrant, Coalition for Epidemic Preparedness Innovations and the University of Oxford, dated as of December 20, 2023
Funding Agreements
Vaccitech plc
Biotechnology
2024
Funding Satisfaction Agreement
Funding Agreements
Aptose Biosciences Inc.
Biotechnology
2024
Amendment Letter, dated November 8, 2023, by and between Elutia Inc. and SWK Funding LLC
Funding Agreements
AZIYO BIOLOGICS, INC.
Biotechnology
2023
Bridge Funding Agreement, dated as of July 11, 2023, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P
Funding Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Amended and Restated Research Funding Agreement, dated May 22, 2023, by and between the Company and Dr. Stanislaw R. Burzynski
Funding Agreements
BURZYNSKI RESEARCH INSTITUTE INC
Biotechnology
2023
Research Funding and Option Agreement, dated March 17, 2023, between the Company and the Scripps Research Institute
Funding Agreements
Xenetic Biosciences, Inc.
Biotechnology
2023
Funding Agreement, dated as of May 26, 2010, by and between the Registrant and The Wellcome Trust Limited
Funding Agreements
PTC THERAPEUTICS, INC.
Biotechnology
DE
2023
Amendment to Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition...
Funding Agreements
VBI Vaccines Inc
Biotechnology
2023
Amendments to the Funding Agreement, dated as of May 26, 2010, by and between the Registrant and The Wellcome Trust Limited
Funding Agreements
PTC THERAPEUTICS, INC.
Biotechnology
2023
Master Agreement for the Operational and Technological Funding of NanoSynex between Qualigen Therapeutics, Inc. and NanoSynex Ltd., dated May 26, 2022
Funding Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic...
Funding Agreements
VBI Vaccines Inc
Biotechnology
2022
Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and BC Pinnacle Holdings, LP
Funding Agreements
ARYA Sciences Acquisition Corp II
Biotechnology
NY
2021
Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and NovaQuest Co-Investment Fund XVI, L.P
Funding Agreements
ARYA Sciences Acquisition Corp II
Biotechnology
NY
2021
Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic...
Funding Agreements
VBI Vaccines Inc
Biotechnology
2021
Amendment Number 1 to the iPDP and Budget of the Outbreak Response Funding Agreement (Step 2), entered into on November 2, 2020, between Novavax, Inc. and the Coalition for...
Funding Agreements
NOVAVAX INC
Biotechnology
2021
Funding Agreement by and
Funding Agreements
Biohaven Pharmaceutical Holding Co Ltd.
Biotechnology
DE
2020
Funding Agreement, dated July 14, 2020, by and between the Company and Dolya Holdco 19 Designated Activity Company
Funding Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2020
Research Funding and Option Agreement, dated May 15, 2020, between the Company and the Scripps Research Institute
Funding Agreements
Xenetic Biosciences, Inc.
Biotechnology
2020
Restated Funding Agreement, entered into on May 11, 2020, by and between the Company and the Coalition for Epidemic Preparedness Innovations
Funding Agreements
NOVAVAX INC
Biotechnology
2020
Litigation Funding Agreement dated April 9, 2020, between BSLF, L.L.C. and BioCardia, Inc
Funding Agreements
BioCardia, Inc.
Biotechnology
FL
2020
Litigation Funding Agreement, dated as of December 27, 2019, between LEGALIST FUND II, L.P. and DiaMedica Therapeutics Inc
Funding Agreements
DiaMedica Therapeutics Inc.
Biotechnology
CA
2020
Funding Agreement, dated as of December 1, 2019, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Baker Bros. Advisors, LP
Funding Agreements
Kodiak Sciences Inc.
Biotechnology
DE
2019
Funding Agreement, as amended, dated June 2, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P
Funding Agreements
VICAL INC
Biotechnology
NY
2019
First Amendment, effective as of October 11, 2018, to the Funding Agreement, dated as of July 10, 2018, by and between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund...
Funding Agreements
Dermavant Sciences Ltd
Biotechnology
DE
2019
Funding Agreement, dated as of July 10, 2018, by and between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P
Funding Agreements
Dermavant Sciences Ltd
Biotechnology
NY
2019
Funding Agreement, dated June 18, 2018, by and between Biohaven Pharmaceutical Holding Company Ltd. and RPI Finance Trust
Funding Agreements
Biohaven Pharmaceutical Holding Co Ltd.
Biotechnology
DE
2018
Funding Agreement, dated as of January 7, 2018, between the Company and RPI Finance Trust
Funding Agreements
IMMUNOMEDICS INC
Biotechnology
NY
2018
Funding contract, dated March 23, 2017, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated July 14, 2016, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated July 20, 2015, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated July 20, 2015, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated June 9, 2014, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated April 3, 2014, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated August 6, 2013, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated March 29, 2013, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated December 5, 2012, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated September 20, 2011, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding Commitment issued by Heat Biologics, Inc. dated April 6, 2017
Funding Agreements
HEAT BIOLOGICS, INC.
Biotechnology
2017
Amended and Restated Investment Agreement dated May 19, 2015 with LG Capital Funding , LLC
Funding Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015